InicioOPL • ASX
add
Opyl Ltd
Cierre anterior
0,019 $
Intervalo anual
0,014 $ - 0,033 $
Cap. bursátil
2,75 M AUD
Volumen medio
110,33 mil
Relación precio-beneficio
-
Rentabilidad por dividendo
-
Bolsa de valores principal
ASX
Noticias sobre los mercados
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
| (AUD) | dic 2024info | Cambio interanual |
|---|---|---|
Ingresos | 167,72 mil | 37,65 % |
Gastos operativos | 323,38 mil | 42,41 % |
Ingresos netos | -341,60 mil | 46,47 % |
Margen de beneficio neto | -203,67 | 61,11 % |
Beneficios por acción | — | — |
EBITDA | -318,04 mil | 25,38 % |
Tipo impositivo efectivo | — | — |
Balance general
Activos totales
Responsabilidades totales
| (AUD) | dic 2024info | Cambio interanual |
|---|---|---|
Efectivo y a corto plazo | 329,55 mil | -43,64 % |
Activos totales | 384,82 mil | -41,63 % |
Responsabilidades totales | 695,82 mil | -3,76 % |
Patrimonio total | -310,99 mil | — |
Acciones en circulación | 170,80 M | — |
Precio-valor contable | ∞ | — |
Rentabilidad económica | -208,46 % | — |
Retorno sobre capital | -683,20 % | — |
Flujo de caja
Variación neta del flujo de caja
| (AUD) | dic 2024info | Cambio interanual |
|---|---|---|
Ingresos netos | -341,60 mil | 46,47 % |
Efectivo de operaciones | -309,99 mil | -6,88 % |
Efectivo de inversión | -662,00 | — |
Efectivo de financiación | 288,10 mil | -19,06 % |
Variación neta del flujo de caja | -22,55 mil | -134,21 % |
Flujo de caja libre | -200,74 mil | 18,01 % |
Información sobre la empresa
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Fundación
2013
Sitio web
Empleados
3
